AMI CHOI: Open Payments
NPI 1083792311 · SAN YSIDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 42 payments from 12 companies in 2025. Trend: 2023 $769 · 2024 $1,064 · 2025 $1,512
Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $352 |
| Incyte Corporation | 13 | $331 |
| Arcutis Biotherapeutics, Inc. | 5 | $196 |
| GENZYME CORPORATION | 4 | $179 |
| Organon LLC | 1 | $150 |
| Galderma Laboratories, L.P. | 1 | $111 |
| Lilly USA, LLC | 2 | $44 |
| Amgen Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $35 |
| LEO Pharma Inc. | 1 | $29 |
Products named: Bimzelx, OPZELURA, Zoryve, DUPIXENT, VTAMA, NEMLUVIO, TALTZ, Otezla.
Industry payments across CA — which companies pay providers there.
